Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Longitudinal Assessment of Chemotherapy-Induced Alterations in Brain Activation During Multitasking and Its Relation With Cognitive Complaints
Sabine Deprez, Mathieu Vandenbulcke, Ronald Peeters, et al.
Journal of Clinical Oncology (2014) Vol. 32, Iss. 19, pp. 2031-2038
Open Access | Times Cited: 72

Showing 1-25 of 72 citing articles:

Cancer-related cognitive impairment: an update on state of the art, detection, and management strategies in cancer survivors
Marie Lange, Florence Joly, Janette Vardy, et al.
Annals of Oncology (2019) Vol. 30, Iss. 12, pp. 1925-1940
Open Access | Times Cited: 484
Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer‐related cognitive impairment in adults
Jeffrey S. Wefel, Shelli R. Kesler, Kyle R. Noll, et al.
CA A Cancer Journal for Clinicians (2014) Vol. 65, Iss. 2, pp. 123-138
Open Access | Times Cited: 457
Treatment of colorectal cancer in older patients: International Society of Geriatric Oncology (SIOG) consensus recommendations 2013
Demetris Papamichael, Riccardo A. Audisio, Bengt Glimelius, et al.
Annals of Oncology (2014) Vol. 26, Iss. 3, pp. 463-476
Closed Access | Times Cited: 406
Systematic review of self-reported cognitive function in cancer patients following chemotherapy treatment
Victoria Bray, Haryana M. Dhillon, Janette Vardy
Journal of Cancer Survivorship (2018) Vol. 12, Iss. 4, pp. 537-559
Closed Access | Times Cited: 149
Cognitive impairment in breast cancer survivors treated with chemotherapy depends on control group type and cognitive domains assessed: A multilevel meta-analysis
Lori J. Bernstein, Graham A. McCreath, Zahra Komeylian, et al.
Neuroscience & Biobehavioral Reviews (2017) Vol. 83, pp. 417-428
Closed Access | Times Cited: 132
Longitudinal assessment of chemotherapy-induced changes in brain and cognitive functioning: A systematic review
Mingmei Li, Karen Caeyenberghs
Neuroscience & Biobehavioral Reviews (2018) Vol. 92, pp. 304-317
Closed Access | Times Cited: 107
Chemotherapy-Related Neurotoxicity
Sophie Taillibert, Émilie Le Rhun, Marc C. Chamberlain
Current Neurology and Neuroscience Reports (2016) Vol. 16, Iss. 9
Closed Access | Times Cited: 97
Measuring Self-Reported Cancer-Related Cognitive Impairment: Recommendations From the Cancer Neuroscience Initiative Working Group
Ashley M. Henneghan, Kathleen Van Dyk, Tara Kaufmann, et al.
JNCI Journal of the National Cancer Institute (2021) Vol. 113, Iss. 12, pp. 1625-1633
Open Access | Times Cited: 76
International Cognition and Cancer Task Force Recommendations for Neuroimaging Methods in the Study of Cognitive Impairment in Non-CNS Cancer Patients
Sabine Deprez, Shelli R. Kesler, Andrew J. Saykin, et al.
JNCI Journal of the National Cancer Institute (2017) Vol. 110, Iss. 3, pp. 223-231
Open Access | Times Cited: 84
Disrupted brain network functional dynamics and hyper‐correlation of structural and functional connectome topology in patients with breast cancer prior to treatment
Shelli R. Kesler, Marjorie Adams, Melissa Packer, et al.
Brain and Behavior (2017) Vol. 7, Iss. 3
Open Access | Times Cited: 73
Chemotherapy-induced brain changes in breast cancer survivors: evaluation with multimodality magnetic resonance imaging
Yun Feng, Xiao Dong Zhang, Gang Zheng, et al.
Brain Imaging and Behavior (2019) Vol. 13, Iss. 6, pp. 1799-1814
Closed Access | Times Cited: 59
Neuromarkers of fatigue and cognitive complaints following chemotherapy for breast cancer: a prospective fMRI investigation
Mary K. Askren, Mi Sook Jung, Marc G. Berman, et al.
Breast Cancer Research and Treatment (2014) Vol. 147, Iss. 2, pp. 445-455
Open Access | Times Cited: 62
Changes in brain activation in breast cancer patients depend on cognitive domain and treatment type
Sanne Menning, Michiel B. de Ruiter, Dick J. Veltman, et al.
PLoS ONE (2017) Vol. 12, Iss. 3, pp. e0171724-e0171724
Open Access | Times Cited: 51
The Developmental Trajectory of Cancer-Related Cognitive Impairment in Breast Cancer Patients: A Systematic Review of Longitudinal Neuroimaging Studies
Helena Sousa, Susana Almeida, João M. Bessa, et al.
Neuropsychology Review (2020) Vol. 30, Iss. 3, pp. 287-309
Open Access | Times Cited: 46
Effects of a mindfulness‐based intervention on cancer‐related cognitive impairment: Results of a randomized controlled functional magnetic resonance imaging pilot study
Katleen Van der Gucht, Soumaya Ahmadoun, Michelle Melis, et al.
Cancer (2020) Vol. 126, Iss. 18, pp. 4246-4255
Open Access | Times Cited: 46
Brain structure and function in patients with ovarian cancer treated with first-line chemotherapy: a pilot study
Denise D. Correa, James C. Root, Maria Kryza‐Lacombe, et al.
Brain Imaging and Behavior (2016) Vol. 11, Iss. 6, pp. 1652-1663
Open Access | Times Cited: 42
Chemotherapy-induced neurotoxicity in pediatric solid non-CNS tumor patients: An update on current state of research and recommended future directions
Charlotte Sleurs, Sabine Deprez, Louise Emsell, et al.
Critical Reviews in Oncology/Hematology (2016) Vol. 103, pp. 37-48
Closed Access | Times Cited: 35
A systemic literature review of neuroimaging studies in women with breast cancer treated with adjuvant chemotherapy
Paulina Andryszak, Monika Wiłkość-Dębczyńska, Paweł Izdebski, et al.
Współczesna Onkologia (2017) Vol. 1, pp. 6-15
Open Access | Times Cited: 34
Should age impact breast cancer management in young women? Fine tuning of treatment guidelines
Matteo B. Suter, Olivia Pagani
Therapeutic Advances in Medical Oncology (2018) Vol. 10
Open Access | Times Cited: 34
Age‐dependent brain volume and neuropsychological changes after chemotherapy in breast cancer patients
Jeroen Blommaert, Gwen Schroyen, Mathieu Vandenbulcke, et al.
Human Brain Mapping (2019) Vol. 40, Iss. 17, pp. 4994-5010
Open Access | Times Cited: 32
Cortical Brain Age from Pre-treatment to Post-chemotherapy in Patients with Breast Cancer
Ashley M. Henneghan, Vikram Rao, Rebecca A. Harrison, et al.
Neurotoxicity Research (2020) Vol. 37, Iss. 4, pp. 788-799
Open Access | Times Cited: 31
Chemo-brain: An activation likelihood estimation meta-analysis of functional magnetic resonance imaging studies
Lori J. Bernstein, Kim Edelstein, Alisha Sharma, et al.
Neuroscience & Biobehavioral Reviews (2021) Vol. 130, pp. 314-325
Closed Access | Times Cited: 24
Chemotherapy-Related Cognitive Impairment in Patients with Breast Cancer Based on Functional Assessment and NIRS Analysis
Noelia Durán-Gómez, Casimiro Fermín López-Jurado, Marta Nadal-Delgado, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 9, pp. 2363-2363
Open Access | Times Cited: 17
The impact of mindfulness on cancer‐related cognitive impairment in breast cancer survivors with cognitive complaints
Michelle Melis, Gwen Schroyen, Nicolas Leenaerts, et al.
Cancer (2023) Vol. 129, Iss. 7, pp. 1105-1116
Open Access | Times Cited: 10
Long-term subjective cognitive functioning following adjuvant systemic treatment: 7–9 years follow-up of a nationwide cohort of women treated for primary breast cancer
Ali Amidi, Steffen Christensen, Mimi Mehlsen, et al.
British Journal of Cancer (2015) Vol. 113, Iss. 5, pp. 794-801
Open Access | Times Cited: 31
Page 1 - Next Page

Scroll to top